Inhibition of microglial fatty acid amide hydrolase modulates LPS stimulated release of inflammatory mediators

[1]  K. Mackie,et al.  Cannabinoid receptors and endocannabinoids: Evidence for new players , 2006, The AAPS Journal.

[2]  E. Cudaback,et al.  Identification of a Novel Endocannabinoid-Hydrolyzing Enzyme Expressed by Microglial Cells , 2007, The Journal of Neuroscience.

[3]  Daniele Piomelli,et al.  Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597). , 2006, CNS drug reviews.

[4]  R. Nitsch,et al.  The Endocannabinoid Anandamide Protects Neurons during CNS Inflammation by Induction of MKP-1 in Microglial Cells , 2006, Neuron.

[5]  G. Cabral,et al.  Cannabinoid receptors in microglia of the central nervous system: immune functional relevance , 2005, Journal of leukocyte biology.

[6]  E. Ponomarev,et al.  Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli , 2005, Journal of neurochemistry.

[7]  M. Racke,et al.  Agonists for the peroxisome proliferator‐activated receptor‐α and the retinoid X receptor inhibit inflammatory responses of microglia , 2005, Journal of neuroscience research.

[8]  C. Guaza,et al.  Activation of the endocannabinoid system as a therapeutic approach in a murine model of multiple sclerosis , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  B. Cravatt,et al.  Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia , 2004, Pain.

[10]  W. Campbell,et al.  Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism. , 2004, Molecular pharmacology.

[11]  T. Rao,et al.  Microglial activation state and lysophospholipid acid receptor expression , 2003, International Journal of Developmental Neuroscience.

[12]  T. Lovenberg,et al.  A high-throughput-compatible assay for determining the activity of fatty acid amide hydrolase. , 2003, Analytical biochemistry.

[13]  B. Cravatt,et al.  Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[14]  D. Boger,et al.  Exceptionally potent inhibitors of fatty acid amide hydrolase: the enzyme responsible for degradation of endogenous oleamide and anandamide. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[15]  G. Cabral,et al.  Cannabinoids inhibit LPS‐inducible cytokine mRNA expression in rat microglial cells , 2000, Glia.

[16]  Kojima,et al.  Fluorescent Indicators for Imaging Nitric Oxide Production. , 1999, Angewandte Chemie.

[17]  G. Cabral,et al.  The central cannabinoid receptor (CB1) mediates inhibition of nitric oxide production by rat microglial cells. , 1999, The Journal of pharmacology and experimental therapeutics.

[18]  Stephen P. Mayfield,et al.  Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides , 1996, Nature.

[19]  D Giulian,et al.  Characterization of ameboid microglia isolated from developing mammalian brain , 1986, The Journal of neuroscience : the official journal of the Society for Neuroscience.